Dermatology
News
Benzene Detected in Benzoyl Peroxide Products: Debate On Implications Continues
“This is a problem of degradation, not contamination,” according to David Light, CEO and founder of Valisure.
News
Nemolizumab Efficacy for Prurigo Nodularis Persists at 1 Year
The 52-week analysis included 307 patients on continuous nemolizumab and 174 patients randomized previously to placebo and were nemolizumab-naive...
News
Approval of Spesolimab for Generalized Pustular Psoriasis Expanded
Spesolimab is an injectable antibody that blocks the IL-36 receptor, a key part of the pathway shown to be involved in the cause of GPP.
News
LITE Study Provides Encouraging Data on Home-Based Phototherapy for Psoriasis
Office-based phototherapy is not available in 90% of counties in the United States, “and a lack of US data has resulted in many insurance...
News
BTK Inhibitor Shows Promise for Hidradenitis Suppurativa
The novel drug is also under investigation in other immune-mediated inflammatory diseases, including chronic spontaneous urticaria and multiple...
News
Acne in Transmasculine Patients: Management Recommendations
Transmasculine patients with acne require unique care that not only is sensitive but also reflects an understanding about factors that can affect...
News
Novel Agent Shows Promise for Hidradenitis Suppurativa
Longer-term phase 3 trials are planned to further examine the safety and efficacy of sonelokimab at the 120 mg dose.
News
Topical Roflumilast Effective in 4 Weeks for Atopic Dermatitis in Young Children
The proportions of patients who reached “clear” (0) or “almost clear” (1) on the vlGA-AD scale were 35.4% and 14.6%, respectively, at week 4.
News
Sustained Control Reported for Anti–IL-17, Anti–IL-23 Psoriasis Treatments
Longer follow up is with the IL-17 inhibitor bimekizumab. In a 4-year open-label extension study, the PASI 90 rate was approximately 85% in...
News
Allergens Present in Most ‘Hypoallergenic’ Baby Cleansers, Study Finds
In the 50 cleansers tested, 10 allergens were identified.